Physician profile
Lisa Bailey
NPI 1861462251
$2,161.69
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,410 · 2020: $87.31 · 2021: $558 · 2022: $50.45 · 2023: $36.83 · 2024: $19.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $388.14 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $192.27 | 2019-2021 | |
| Focal Therapeutics, INC. | $172.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $142.56 | 2019-2022 | |
| Amgen INC. | $121.65 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $119.07 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $118.93 | 2019-2021 | |
| Celgene Corporation | $98.85 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $93.99 | 2019 | |
| Tersera Therapeutics LLC | $79.56 | 2019-2023 | Zoladex |
| Pharmacyclics LLC, An Abbvie Company | $67.23 | 2019-2023 | Imbruvica |
| Astellas Pharma US INC | $62.89 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.03 | 2019 | |
| Seagen INC. | $44.46 | 2021 | |
| Eisai INC. | $44.46 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $43.81 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $35.70 | 2019 | |
| Emd Serono, INC. | $32.36 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $27.65 | 2021 | |
| Tesaro, INC. | $26.87 | 2019 | |
| Exelixis INC. | $24.81 | 2019 | |
| Alexion Pharmaceuticals, INC. | $24.40 | 2019 | |
| Genzyme Corporation | $24.20 | 2020 | |
| Daiichi Sankyo INC. | $23.78 | 2020 | |
| Janssen Biotech, INC. | $19.52 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $19.30 | 2024 | Iort |
| Lexicon Pharmaceuticals, INC. | $17.45 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.41 | 2021 | |
| Pfizer INC. | $16.58 | 2019 | |
| Lilly USA, LLC | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.